PHAT - Phathom Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PHAT is currently covered by 6 analysts with an average price target of $23.18. This is a potential upside of $12.34 (177.27%) from yesterday's end of day stock price of $8.36.

Phathom Pharmaceuticals's activity chart (see below) currently has 75 price targets and 95 ratings on display. The stock rating distribution of PHAT is 91.67% BUY and 8.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 23.21% with an average time for these price targets to be met of 84.45 days.

Highest price target for PHAT is $29, Lowest price target is $14, average price target is $23.18.

Most recent stock forecast was given by GLEN SANTANGELO from BARCLAYS on 17-Aug-2026.

Best performing analysts who are covering PHAT - Phathom Pharmaceuticals:

Paul Choi Glen Santangelo Kristen Kluska Chase Knickerbocker

Currently out of the existing stock ratings of PHAT, 11 are a BUY (91.67%), 1 are a HOLD (8.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 17-Aug-2026

$14

$5.64 (67.46%)

$18

27 days ago
(17-Aug-2026)

2/4 (50%)

$4.72 (50.86%)

444

Buy Since 02-Feb-2021

$22

$13.64 (163.16%)

$25

1 months 13 days ago
(31-Jul-2026)

1/7 (14.29%)

$13.25 (151.43%)

134

Buy Since 09-Aug-2023

$26

$17.64 (211.00%)

$26

1 months 13 days ago
(31-Jul-2026)

0/10 (0%)

$17.25 (197.14%)

Buy Since 02-Mar-2022

$22

$13.64 (163.16%)

$28

1 months 14 days ago
(30-Jul-2026)

0/45 (0%)

$12.97 (143.63%)

Buy Since 07-Mar-2025

$22

$11.28 (105.22%)

$17

10 months 13 days ago
(31-Oct-2025)

1/3 (33.33%)

$8.45 (62.36%)

193

Show more analysts

Please expand the browser size to see the chart

What is PHAT (Phathom Pharmaceuticals) average time for price targets to be met?

On average it took 84 days for the stock forecasts to be reached, with an average price target met ratio of 23.21%.

Which analyst most recently updated their price target on PHAT (Phathom Pharmaceuticals)?

Glen Santangelo

Which analyst has the most public recommendations on PHAT (Phathom Pharmaceuticals)?

Glen Santangelo works at BARCLAYS and has 12 price targets and 9 ratings on PHAT

Which analyst is the currently most bullish on PHAT (Phathom Pharmaceuticals)?

Prakhar Agrawal with the highest potential upside of $49.37

Which analyst is the currently most reserved on PHAT (Phathom Pharmaceuticals)?

Paul Choi with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?